Three Pivotal Drug Policy Organizations Hold Media
Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths...
Source: globenewswire.com
Stay updated with breaking news from Zendo Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Executives from MAPS, NORML, and MPP to Celebrate DEA Rescheduling of Cannabis to Schedule III Drug and Debunk Myths...
MAPS uses its over 30 years of experience in the psychedelic space to offer a first-of-its-kind gold-standard training program. ...
10+ stages, a city block of exhibitor space, dozens of workshops, and a whole universe of networking and social events planned...
The FDA has accepted Lykos Therapeutics' New Drug Application, supported by two decades of research incubated by MAPS, for MDMA-assisted therapy for PTSD....